Featured Research

from universities, journals, and other organizations

Early childhood neglect may raise risk of adult skin cancer

Date:
June 4, 2012
Source:
Ohio State University
Summary:
Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, new research suggests.

Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based on a new study.

The research suggests that such experiences during a person's youth can set a lower level of immune response for life, which in turn might make them more susceptible to the kind of cancers that are often successfully fought by the immune system, so-called immunogenic tumors.

While the research focused on patients with a fairly benign form of skin cancer -- basal cell carcinoma (BCC) -- the findings appear as a warning for patients to be more vigilant in concerns over their health for the rest of their lives.

The study appears in the June 4, 2012, issue of the journal Archives of General Psychiatry and is the latest in three decades of research linking stress and immunity that have been led by investigators at Ohio State University's Institute for Behavioral Medicine Research (IBMR).

"This is the first study to show that troubled early parental experiences, in combination with a severe life event in the past year, predict local immune responses to a BCC tumor," wrote Christopher Fagundes, first author of the paper and a postdoctoral fellow at the IBMR.

"This expands the growing evidence that the consequences of early parental experiences extend well beyond childhood."

Basal cell tumors are considered the most common form of skin cancer, and much less dangerous than squamous cell carcinomas or melanomas. And their frequency is on the rise, the number having doubled in the United States every 14 years. Nearly half of all BCC patients will have an additional tumor form within three years of their first.

The researchers looked at 91 men and women who previously had a BCC. Each of the participants were given a battery of surveys and interviews, some of which gauged their past relationship with their parents as children. From this, the researchers could measure the degree of neglect or maltreatment the patients had experienced as children.

Tissue from each participant's tumors was also analyzed and tested for the presence of four types of messenger RNA, markers that measured the intensity of the person's immune response to their tumor.

The results showed that BCC patients who had a severe, stressful life event in the last year, and who experienced neglect or maltreatment from their mothers as children, had a substantial drop in their immune response to the tumors.

"Those in the top 25 percent of maltreatment by their mothers saw a 350 percent reduction in immunity compared to those in the bottom 25 percent of maltreatment," Fagundes explained.

Maltreatment or neglect from the father showed a 140 percent drop in immunity when the top 25 percent were compared to the bottom 25 percent, he said.

"We're not talking about abuse here," he explained. "And the effects were similar regardless of whether the harm came from the mother or father."

Jan Kiecolt-Glaser, co-author of the paper and a professor of psychiatry and psychology at Ohio State, said, "This means that for people who have had an early history of vulnerability and who are currently going through a stressful period, they have another reason to watch their health and be especially vigilant."

The findings are likely to be significant beyond just their role with BCC patients, said Ron Glaser, another co-author and director of the IBMR. Glaser, a professor of molecular virology, immunology and medical genetics, pointed to other immunogenic cancers that might be affected.

"If the immune system is down-regulated, it will affect a person's ability to deal with that tumor," he said. "Some examples of other immunogenic tumors include ovarian cancer, head and neck cancers, melanoma, some lymphomas and tumors induced by cancer viruses, and renal cell tumors."

The researchers hope to continue the work and determine what mechanisms are responsible for the continued lower immune response.

Support for this work came from the National Cancer Institute and the American Cancer Society.


Story Source:

The above story is based on materials provided by Ohio State University. The original article was written by Earle Holland. Note: Materials may be edited for content and length.


Journal Reference:

  1. Christopher P. Fagundes et al. Basal Cell CarcinomaStressful Life Events and the Tumor Environment. Archives of General Psychiatry, 2012 DOI: 10.1001/archgenpsychiatry.2011.1535

Cite This Page:

Ohio State University. "Early childhood neglect may raise risk of adult skin cancer." ScienceDaily. ScienceDaily, 4 June 2012. <www.sciencedaily.com/releases/2012/06/120604181618.htm>.
Ohio State University. (2012, June 4). Early childhood neglect may raise risk of adult skin cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/06/120604181618.htm
Ohio State University. "Early childhood neglect may raise risk of adult skin cancer." ScienceDaily. www.sciencedaily.com/releases/2012/06/120604181618.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins